Plain-English translation of NCT06805786 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This trial is testing whether switching from a FreeStyle Libre 2 glucose monitor (which you scan manually) to a Dexcom G7 glucose monitor (which reads continuously and automatically) helps people with type 2 diabetes manage their blood sugar better. The study will compare your blood sugar control and quality of life if you switch to the newer device, versus if you keep using your current monitor.
Many people with diabetes use glucose monitors to check their blood sugar levels, but some monitors require you to manually scan them while others work automatically in the background. Researchers want to understand whether the automatic, real-time monitor leads to better blood sugar control and a better experience for patients.
You likely qualify if…
You likely don't qualify if…
If you are in the group switching to the newer monitor, you will receive the Dexcom G7 device and complete surveys about how satisfied you are with it and how you're feeling at the start and after 3–6 months. If you stay in the group continuing with your current monitor, you will have your blood sugar data reviewed during the same time period. All participants will have their blood sugar levels, insulin doses, and other health measures tracked over 3–6 months.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Canada